Journals / Eurasian Journal of Medicine / 2016 / Cilt: 48 - Sayı: 3

Pediatrik Karaciğer Transplantasyonu: Tek Merkez Deneyimi

Pediatric Liver Transplantation: Our Experiences

Pages
209–212
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Bile leakage and biliary stricture rates were 31% and 11%, respectively. 1-year and 5-year survival rates of our patients were 87% and 84%, respectively.Conclusion: The morbidity and mortality rates in our organ transplantation center, regarding pediatric liver transplantations, are consistent with the literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of our study was to evaluate our liver transplant pediatric patients and to report our experience in the complications and the long-term follow-up results.Materials and Methods: Patients between the ages of 0 and 18 years, who had liver transplantation in the organ transplantation center of our university hospital between 1997 and 2016, were included in the study.
📊
Key Findings & Data:The obtained results were analyzed with statistical methods.Results: In our organ transplantation center, 62 pediatric liver transplantations were carried out since 1997.
💡
Conclusion & Impact:Bile leakage and biliary stricture rates were 31% and 11%, respectively. 1-year and 5-year survival rates of our patients were 87% and 84%, respectively.Conclusion: The morbidity and mortality rates in our organ transplantation center, regarding pediatric liver transplantations, are consistent with the literature.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of our study was to evaluate our liver transplant pediatric patients and to report our experience in the complications and the long-term follow-up results.Materials and Methods: Patients between the ages of 0 and 18 years, who had liver transplantation in the organ transplantation center of our university hospital between 1997 and 2016, were included in the study. The age, sex, indications for the liver transplantation, complications after the transplantation, and long-term follow-up findings were retrospectively evaluated. The obtained results were analyzed with statistical methods.Results: In our organ transplantation center, 62 pediatric liver transplantations were carried out since 1997. The mean age of our patients was 7.3 years (6.5 months-17 years). The 4 most common reasons for liver transplantation were: Wilson's disease (n=10; 16.3%), biliary atresia (n=9; 14.5%), progressive familial intrahepatic cholestasis (n=8; 12.9%), and cryptogenic cirrhosis (n=7; 11.3%). The mortality rate after transplantation was 19.6% (12 of the total 62 patients). The observed acute and chronic rejection rates were 34% and 4.9%, respectively. Thrombosis (9.6%) was observed in the hepatic artery (4.8%) and portal vein (4.8%). Bile leakage and biliary stricture rates were 31% and 11%, respectively. 1-year and 5-year survival rates of our patients were 87% and 84%, respectively.Conclusion: The morbidity and mortality rates in our organ transplantation center, regarding pediatric liver transplantations, are consistent with the literature.

Özet

Amaç: Çalışmamızın amacı pediatrik karaciğer nakilli hastalarımızı değerlendirerek deneyim, komplikasyonlar ve uzun süreli izlem sonuçlarımızı bildirmektir.Gereç ve Yöntem: Üniversite hastanesi organ nakil merkezinde 1997 ile 2016 yılları arasında karaciğer nakli yapılmış 0-18 yaş arasındaki hastalar ile çalışma yapılmıştır. Hastaların yaş, cinsiyet, karaciğer nakil endikasyonu, nakil sonrası komplikasyonlar ve uzun süreli izlem bulguları retrospektif olarak değerlendirilmiştir. Elde edilen sonuçların istatistiksel analizi yapılmıştır.Bulgular: 1997'den bu yana organ nakli ünitemizde toplam 62 çocuk hastaya karaciğer nakili yapılmıştır. Ortalama yaş 7,3 yıl saptandı (6,5 ay-17 yaş). Karaciğer nakil endikasyonlarının en sık 4 nedenini sırasıyla Wilson hastalığı %16,3 (10 hasta), bilier atrezi %14,5 (9 hasta), progressif familyal intrahepatik kolestaz %12,9 (8 hasta), kriptojenik siroz %11,3 (7 hasta), oluşturuyordu. Nakil sonrası mortalitemiz %19,6 oranında idi (toplam 62 hastanın 12'de). Akut rejeksiyon %34 oranında, kronik rejeksiyon ise %4,9 oranında gözlenmiştir. Tromboz %9,6 oranında gözlenmiş olup % 4,8 oranında hepatik arterde ve %4,8 oranında portal vende gözlendi. Bilier sızıntı %31 oranında gözlenmiş olup bilier darlık ise %11 oranında gözlenmiştir. Hastalarımızın 1 yıllık sağ kalımı %87 ve 5 yıllık sağ kalımı %84 saptanmıştır.Sonuç: Organ nakli merkezimizin, çocukluk döneminde yaptığı karaciğer nakillerinin morbidite ve mortalite verileri literatür ile uyumludur.

🔖

Cite This Article

YILMAZ, A., ALİOSMANOĞLU, İ., ERBİŞ, H., SAYAR, E., BASTURK, A., ARTAN, R., AYDINLI, B., DİNÇHAN, A. (2022). Pediatrik Karaciğer Transplantasyonu: Tek Merkez Deneyimi. Eurasian Journal of Medicine, Cilt: 48 - Sayı: 3, 209–212. https://ajindex.com/articles/509073

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. National Institutes of Health Consensus Development Conference Statement: liver trans- plantation--June 20-23, 1983. Hepatology 1984; 4: 107S-10S. [CrossRef] Kamath BM, Olthoff KM. Liver transplantation in children: update 2010. Pediatr Clin North Am 2010; 57: 401-14. [CrossRef] Spada M, Riva S, Maggiore G, Cintorino D, Gridelli B. Pediatric liver transplantation. World J Gastroenterol 2009; 15: 648-74. [CrossRef] Strobele B, Loveland J, Gottlich E, Britz R, Welthagen A, Botha JF. Combined paediatric liver-kidney trans- plantation: Analysis of our experience and literature review. S Afr Med J 2013; 103: 925-9. [CrossRef] Holmes RD, Orban-Eller K, Karrer FR, Rowe DT, Narkewicz MR, Sokol RJ. Response of elevated EpsteinBarr virus DNA levels to therapeutic changes in pediatric liver transplant patients: 56-month follow up and outcome. Transplantation 2002; 74: 367-72. [CrossRef] Holmes RD, Sokol RJ. Epstein-Barr virus and post- transplant lymphoproliferative disease. Pediatr Transplant 2002; 6: 456-64. [CrossRef] Kelly DA, Mayer D. Liver Transplantation. in Diseases of the liver and biliary system in children (eds) Deirdre Kelly 3rd edition. Blacwell Publishing West Sussex UK, 2008; p: 503 McDiarmid SV. Management of the pediatric liver trans- plant patient. Liver Transpl 2001; 7: 77 86. [CrossRef] Basso MS, Subramaniam P, Tredger M, et al. Sirolimus as renal and immunological rescue agent in pediatric liver transplant recipients. Pediatr Transplant 2011; 15: 722 7. [CrossRef] Yazigi NA. Long term outcomes after pediatric liver transplantation. Pediatr Gastroenterol Hepatol Nutr 2013; 16: 207-18. [CrossRef] Moray G, Tezcaner T, Akdur A, et al. Results of pediatric liver transplant: a single-center experi- ence. Exp Clin Transplant 2015; 13: 59-63.
  2. Kamath BM, Olthoff KM. Liver transplantation in children: update 2010. Pediatr Clin North Am 2010; 57: 401-14. [CrossRef] Berg CL, Steffick DE, Edwards EB, et al. Liver and intestine transplantation in the United States 1998- 2007. Am J Transplant 2009; 9: 907-31. [CrossRef] Oh SH, Kim KM, Kim DY, et al. Clinical experience of more than 200 cases of pediatric liver transplan- tation at a single center: improved patient survival. Transplant Proc 2012; 44: 484-6. [CrossRef] Yersiz H, Renz JF, Farmer DG, Hisatake GM, McDiarmid SV, Busuttil RW. One hundred in situ split-liver transplan- tations: a single-center experience. Ann Surg 2003; 238: 496-505; discussion 506-7. [CrossRef] Ackermann O, Branchereau S, Franchi Abel